Global Obsessive-Compulsive Disorder Therapeutics Pipeline Report 2016 - Research and Markets

DUBLIN--()--Research and Markets has announced the addition of the "Obsessive-Compulsive Disorder - Pipeline Review, H2 2016" drug pipelines to their offering.

This report provides comprehensive information on the therapeutic development for Obsessive-Compulsive Disorder, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Obsessive-Compulsive Disorder and special features on late-stage and discontinued projects.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Key Topics Covered:

  1. Introduction
  2. Obsessive-Compulsive Disorder Overview
  3. Therapeutics Development
  4. Pipeline Products for Obsessive-Compulsive Disorder - Overview
  5. Pipeline Products for Obsessive-Compulsive Disorder - Comparative Analysis
  6. Obsessive-Compulsive Disorder - Therapeutics under Development by Companies
  7. Obsessive-Compulsive Disorder - Therapeutics under Investigation by Universities/Institutes
  8. Obsessive-Compulsive Disorder Products Glance
  9. Late Stage Products
  10. Clinical Stage Products
  11. Early Stage Products
  12. Obsessive-Compulsive Disorder - Products under Development by Companies
  13. Obsessive-Compulsive Disorder - Products under Investigation by Universities/Institutes
  14. Obsessive-Compulsive Disorder - Companies Involved in Therapeutics Development
  • AbbVie Inc.
  • Addex Therapeutics Ltd
  • Amorsa Therapeutics Inc.
  • C4X Discovery Holdings PLC
  • Novartis AG
  • Omeros Corporation

For more information about this drug pipelines visit http://www.researchandmarkets.com/research/hl64dm/obsessivecompulsi

Related Topics: Mental Disorders Drugs

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716